Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 1.28 billion. The enterprise value is 1.11 billion.
| Market Cap | 1.28B |
| Enterprise Value | 1.11B |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
Biofarm has 985.37 million shares outstanding.
| Current Share Class | 985.37M |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.43% |
| Float | 476.14M |
Valuation Ratios
The trailing PE ratio is 12.66.
| PE Ratio | 12.66 |
| Forward PE | n/a |
| PS Ratio | 4.00 |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.98 |
| EV / Sales | 3.47 |
| EV / EBITDA | n/a |
| EV / EBIT | 10.43 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 29.09% |
| Return on Capital Employed (ROCE) | 19.28% |
| Weighted Average Cost of Capital (WACC) | 7.04% |
| Revenue Per Employee | 856,125 |
| Profits Per Employee | 270,286 |
| Employee Count | 367 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Biofarm has paid 14.39 million in taxes.
| Income Tax | 14.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.78% in the last 52 weeks. The beta is 0.51, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +88.78% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 0.90 |
| Relative Strength Index (RSI) | 63.35 |
| Average Volume (20 Days) | 180,718 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 319.33 million and earned 100.82 million in profits.
| Revenue | 319.33M |
| Gross Profit | 273.30M |
| Operating Income | 106.10M |
| Pretax Income | 115.20M |
| Net Income | 100.82M |
| EBITDA | n/a |
| EBIT | 106.10M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 170.25 million in cash and 1.13 million in debt, with a net cash position of 169.11 million or 0.17 per share.
| Cash & Cash Equivalents | 170.25M |
| Total Debt | 1.13M |
| Net Cash | 169.11M |
| Net Cash Per Share | 0.17 |
| Equity (Book Value) | 548.53M |
| Book Value Per Share | 0.56 |
| Working Capital | 319.95M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 33.23% |
| Pretax Margin | 36.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 2.39%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 2.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 2.38% |
| Earnings Yield | 7.90% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |